Status: Not yet recruiting
Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer
This study will evaluate the efficacy and safety of Iparomlimab and Tuvonralimab Injection in combination with Chemotherapy and Sequential Thoracic Radiotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer.
Participants needed: 46
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: The Second Affiliated Hospital of Dalian Medical UniversityUpdated: Jan 16, 2026
Eligibility criteria
For voluntary signing of the informed consent form, participants aged 18 to 75 y... [+10]
Patients with allergies or intolerance to the EP chemoradiotherapy regimen or an... [+18]